Annual Current Assets
$47.18 M
-$4.82 M-9.27%
December 31, 2023
Summary
- As of February 7, 2025, BLRX annual total current assets is $47.18 million, with the most recent change of -$4.82 million (-9.27%) on December 31, 2023.
- During the last 3 years, BLRX annual current assets has risen by +$24.30 million (+106.22%).
- BLRX annual current assets is now -17.81% below its all-time high of $57.40 million, reached on December 31, 2021.
Performance
BLRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$37.85 M
-$11.26 M-22.93%
September 1, 2024
Summary
- As of February 7, 2025, BLRX quarterly total current assets is $37.85 million, with the most recent change of -$11.26 million (-22.93%) on September 1, 2024.
- Over the past year, BLRX quarterly current assets has increased by +$9.04 million (+31.40%).
- BLRX quarterly current assets is now -43.57% below its all-time high of $67.07 million, reached on June 30, 2021.
Performance
BLRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
BLRX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.3% | +31.4% |
| 3 y3 years | +106.2% | -39.8% |
| 5 y5 years | +47.5% | -39.8% |
BLRX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.8% | at low | -34.7% | +31.4% |
| 5 y | 5-year | -17.8% | +106.2% | -43.6% | +76.7% |
| alltime | all time | -17.8% | +150.5% | -43.6% | +100.9% |
BioLineRx Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $37.85 M(-22.9%) |
| Jun 2024 | - | $49.11 M(+37.6%) |
| Mar 2024 | - | $35.69 M(-24.4%) |
| Dec 2023 | $16.74 M(-31.3%) | $47.18 M(+63.8%) |
| Sep 2023 | - | $28.80 M(-17.0%) |
| Jun 2023 | - | $34.69 M(-21.7%) |
| Mar 2023 | - | $44.33 M(-14.8%) |
| Dec 2022 | $24.38 M(+1.7%) | $52.00 M(-10.3%) |
| Sep 2022 | - | $57.94 M(+31.4%) |
| Jun 2022 | - | $44.10 M(-13.4%) |
| Mar 2022 | - | $50.94 M(-11.3%) |
| Dec 2021 | $23.99 M(-1.7%) | $57.40 M(-8.7%) |
| Sep 2021 | - | $62.85 M(-6.3%) |
| Jun 2021 | - | $67.07 M(+13.0%) |
| Mar 2021 | - | $59.35 M(+159.4%) |
| Dec 2020 | $24.41 M(-3.7%) | $22.88 M(+6.8%) |
| Sep 2020 | - | $21.42 M(-23.9%) |
| Jun 2020 | - | $28.17 M(+27.2%) |
| Mar 2020 | - | $22.14 M(-21.5%) |
| Dec 2019 | $25.36 M(+4.5%) | $28.21 M(-11.0%) |
| Sep 2019 | - | $31.70 M(-12.4%) |
| Jun 2019 | - | $36.21 M(-13.1%) |
| Mar 2019 | - | $41.65 M(+30.2%) |
| Dec 2018 | $24.25 M(+129.1%) | $31.98 M(-13.8%) |
| Sep 2018 | - | $37.10 M(-13.3%) |
| Jun 2018 | - | $42.80 M(-6.0%) |
| Mar 2018 | - | $45.54 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $10.59 M(+273.1%) | $50.38 M(-9.8%) |
| Sep 2017 | - | $55.85 M(+4.1%) |
| Jun 2017 | - | $53.66 M(+69.6%) |
| Mar 2017 | - | $31.65 M(-12.3%) |
| Dec 2016 | $2.84 M(-9.0%) | $36.10 M(-8.4%) |
| Sep 2016 | - | $39.41 M(-7.7%) |
| Jun 2016 | - | $42.69 M(-6.9%) |
| Mar 2016 | - | $45.87 M(-4.8%) |
| Dec 2015 | $3.12 M(+196.2%) | $48.18 M(-7.1%) |
| Sep 2015 | - | $51.88 M(-6.8%) |
| Jun 2015 | - | $55.69 M(-4.7%) |
| Mar 2015 | - | $58.43 M(+66.2%) |
| Dec 2014 | $1.05 M(-10.7%) | $35.16 M(+17.6%) |
| Sep 2014 | - | $29.90 M(-11.8%) |
| Jun 2014 | - | $33.89 M(-10.4%) |
| Mar 2014 | - | $37.83 M(+100.8%) |
| Dec 2013 | $1.18 M(-44.6%) | $18.84 M(-8.4%) |
| Sep 2013 | - | $20.55 M(-11.9%) |
| Jun 2013 | - | $23.33 M(-19.5%) |
| Mar 2013 | - | $28.98 M(+30.7%) |
| Dec 2012 | $2.13 M(-2.5%) | $22.18 M(-15.6%) |
| Sep 2012 | - | $26.27 M(-16.3%) |
| Jun 2012 | - | $31.37 M(-15.6%) |
| Mar 2012 | - | $37.15 M(+36.8%) |
| Dec 2011 | $2.18 M | $27.16 M(-11.5%) |
| Sep 2011 | - | $30.68 M(-12.6%) |
| Jun 2011 | - | $35.09 M(-8.6%) |
| Mar 2011 | - | $38.38 M |
FAQ
- What is BioLineRx annual total current assets?
- What is the all time high annual current assets for BioLineRx?
- What is BioLineRx annual current assets year-on-year change?
- What is BioLineRx quarterly total current assets?
- What is the all time high quarterly current assets for BioLineRx?
- What is BioLineRx quarterly current assets year-on-year change?
What is BioLineRx annual total current assets?
The current annual current assets of BLRX is $47.18 M
What is the all time high annual current assets for BioLineRx?
BioLineRx all-time high annual total current assets is $57.40 M
What is BioLineRx annual current assets year-on-year change?
Over the past year, BLRX annual total current assets has changed by -$4.82 M (-9.27%)
What is BioLineRx quarterly total current assets?
The current quarterly current assets of BLRX is $37.85 M
What is the all time high quarterly current assets for BioLineRx?
BioLineRx all-time high quarterly total current assets is $67.07 M
What is BioLineRx quarterly current assets year-on-year change?
Over the past year, BLRX quarterly total current assets has changed by +$9.04 M (+31.40%)